Search results
There is a page named "Chronic myelogenous leukemia" on Wikipedia
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells. It is a form of leukemia characterized...34 KB (3,877 words) - 13:44, 25 October 2024- myeloproliferative. Chronic leukemia may refer to: Chronic myelogenous leukemia Chronic lymphocytic leukemia, including Hairy cell leukemia Myeloproliferative...622 bytes (94 words) - 18:41, 18 April 2023
include acute promyelocytic leukemia, acute myeloblastic leukemia, and acute megakaryoblastic leukemia. Chronic myelogenous leukemia (CML) occurs mainly in...83 KB (8,163 words) - 07:50, 6 January 2025- Blastic phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which more than 30% of the cells in the blood or bone marrow...714 bytes (87 words) - 00:48, 10 February 2023
- Accelerated phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which the disease is progressing. Common symptoms include...2 KB (151 words) - 19:57, 17 July 2024
- Chronic phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which 5% or fewer of the cells in the blood and bone marrow are...579 bytes (84 words) - 13:16, 10 July 2019
- production. Chronic myelogenous leukemia: A cancer of the white blood cells. Acute megakaryoblastic leukemia: A life-threatening leukemia in which malignant...2 KB (138 words) - 14:45, 5 April 2024
- acute leukemia in the bone marrow Acute erythroid leukemia, a rare form of acute myeloid leukemia Acute myeloid leukemia Chronic myelogenous leukemia Peripheral...5 KB (457 words) - 04:55, 24 September 2024
prevents the promyelocytes from maturing properly. Chronic myelogenous leukemia (CML) is a chronic leukemia that develops slowly, over months to years. CML...36 KB (4,289 words) - 14:57, 28 February 2024
Imatinib (section Chronic myelogenous leukemia)and PDGFR-β. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome–positive...72 KB (6,714 words) - 16:58, 12 January 2025
effective. If imatinib does not work, patients with advanced chronic myelogenous leukemia can use nilotinib, dasatinib, bosutinib, ponatinib, or another...44 KB (5,283 words) - 12:50, 27 December 2024
the term "acute leukemia" in 1889 to differentiate rapidly progressive and fatal leukemias from the more indolent chronic leukemias. The term "myeloid"...75 KB (7,543 words) - 18:38, 10 December 2024- associated with ALL and AML. p230 is usually associated with chronic myelogenous leukemia associated with neutrophilia and thrombocytosis (CML-N). Additionally...29 KB (3,538 words) - 15:01, 5 December 2023
- Primary myelofibrosis (redirect from Chronic idiopathic myelofibrosis)Media, LLC. pp. 28–. ISBN 978-0-387-73744-7. Karp JE (2007). Acute myelogenous leukemia. Humana Press. pp. 385–. ISBN 978-1-58829-621-4. Retrieved 13 November...27 KB (2,844 words) - 06:22, 5 January 2025
cells. Lymphomas, lymphocytic leukemias, and myeloma are from the lymphoid line, while acute and chronic myelogenous leukemia, myelodysplastic syndromes...24 KB (2,329 words) - 20:43, 2 October 2024- leukocyte alkaline phosphatase values) suggest the diagnosis of chronic myelogenous leukemia (CML). However the lack of the pathognomonic Philadelphia chromosome...8 KB (721 words) - 21:56, 8 January 2024
Neprilysin (redirect from Common acute lymphoblastic leukemia antigen)lymphoma, chronic myelogenous leukemia in blast crisis (90%), diffuse large B-cell lymphoma (variable), follicular center cells (70%), hairy cell leukemia (10%)...23 KB (2,581 words) - 06:57, 21 July 2024
medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Specifically it is used to treat cases...22 KB (1,994 words) - 16:56, 12 January 2025- acute leukemia. Serum leukocyte alkaline phosphatase is normal or elevated in leukemoid reaction, but is depressed in chronic myelogenous leukemia. The...5 KB (469 words) - 21:40, 19 October 2024
and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by Wyeth, it is being developed by Pfizer...10 KB (633 words) - 12:29, 5 August 2024
- C92.1 Chronic myeloid leukemia, BCR/ABL-positive Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive Chronic myelogenous leukemia, t(9:22)
- myeloid leukemia (AML) Acute biphenotypic leukemias Myeloproliferative disease Chronic myelogenous leukemia (CML) Chronic neutrophilic leukemia Chronic eosinophilic